Loblaw Companies Limited · TSX:L
Loblaw Companies — Q3 2023 Earnings Presentation
5 slides from Loblaw Companies's earnings presentation, Oct 7, 2023
Slide 1: Supplementary Slides Q3 2023
SUPPLEMENTARY SLIDES Q3 2023 For the periods ended October 7, 2023 and October 8, 2022 1
Slide 2: Forward Looking Statements
FORWARD LOOKING STATEMENTS This presentation for Loblaw Companies Limited (“Loblaw” or “the Company”) contains forward-looking statements about the Company’s objectives, plans, goals, aspirations, strategies, financial condition, results of operations, cash flows, performance, prospects, opportuniti
Slide 3: Key Financial Metrics – Consolidated
KEY FINANCIAL METRICS – Consolidated Q3 2023 (millions of Canadian dollars unless otherwise noted) Q3 2023 Q3 2022 % Change (1) Consolidated Revenue $18,265 $17,388 ↑ +5.0% Adjusted EBITDA $1,926 $1,846 ↑ +4.3% Adjusted EBITDA Margin 10.5% 10.6% ↓ 10 bps Adjusted Net Earnings Avaliable to Common Sha
Slide 4: Key Financial Metrics – Retail Segment
KEY FINANCIAL METRICS – Retail Segment Q3 2023 (millions of Canadian dollars unless otherwise noted) Q3 2023 Q3 2022 % Change (1) Total Retail Revenue $17,982 $17,130 ↑ 5.0% Retail Revenue - Food $12,843 $12,221 ↑ 5.1% Retail Revenue - Drug $5,139 $4,909 ↑ 4.7% Pharmacy and Healthcare Services $2,63
Slide 5: Key Operational Metrics
KEY OPERATIONAL METRICS Q3 2023 Food Retail (Loblaw) % Change (1) Food Retail Same-Store Sales Growth ↑ +4.5% Basket Size(2) ↓ Traffic(2) ↑ Loblaw STM Square Footage Growth ↑ Industry STM Square Footage Growth ↑ Drug Retail (Shoppers Drug Mart) % Change (1) Drug Retail Same-Store Sales Growth ↑ +4.6